ArticleRMD open2025

Work loss in patients with rheumatoid arthritis treated with abatacept, rituximab, tocilizumab or TNF inhibitors: a nationwide direct drug-to-drug comparison.

Gustaf Magnus Bruze et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.